|
1
|
Gene expression-based classification as an independent predictor of clinical outcome in juvenile myelomonocytic leukemia.
|
J Clin Oncol
|
2010
|
1.25
|
|
2
|
Functional protein network activation mapping reveals new potential molecular drug targets for poor prognosis pediatric BCP-ALL.
|
PLoS One
|
2010
|
0.96
|
|
3
|
New data on robustness of gene expression signatures in leukemia: comparison of three distinct total RNA preparation procedures.
|
BMC Genomics
|
2007
|
0.89
|
|
4
|
Down-regulation of DLX3 expression in MLL-AF4 childhood lymphoblastic leukemias is mediated by promoter region hypermethylation.
|
Oncol Rep
|
2007
|
0.79
|